Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $542.73 ($5.2M) on 2026-10-07, disclosed to the SEC on 2026-10-08.
Scheduled sale ($5.2M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $542.73 | 176 | $96K | 1.8% |
| 2 | $543.76 | 744 | $405K | 7.8% |
| 3 | $544.82 | 2,098 | $1.1M | 21.9% |
| 4 | $545.85 | 493 | $269K | 5.2% |
| 5 | $546.94 | 629 | $344K | 6.6% |
| 6 | $548.18 | 387 |
| $212K |
| 4.1% |
| 7 | $549.13 | 1,173 | $644K | 12.4% |
| 8 | $550.14 | 874 | $481K | 9.2% |
| 9 | $551.09 | 486 | $268K | 5.1% |
| 10 | $552.29 | 440 | $243K | 4.7% |
| 11 | $553.70 | 185 | $102K | 2.0% |
| 12 | $554.51 | 485 | $269K | 5.2% |
| 13 | $555.77 | 930 | $517K | 9.9% |
| 14 | $556.48 | 400 | $223K | 4.3% |
| Total | $548.95 avg | 9,500 | $5.2M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-14 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |
| UTHR | SELL | 2026-10-13 | $5.2M | — | Filing → |